BioSig AI Sciences, a subsidiary of BioSig Technologies, sold 495,000 shares of its common stock to institutional and accredited investors for a total of $495,000. Following the sale, BioSig still retains approximately 84.5% ownership of BioSig AI. The deal was closed on July 19, 2023.